Commercializing Asian and Australasian Herbal Medicines: Market Potential and Strategies

Amina Razzaq ^1*, Huma Ameen ¹, Rida Aziz ²

This review explores the rapidly increasing market potential of herbal medicines in Asia and Australasia, vital for biopharmaceutical and healthcare sectors.

Abstract

This review explores the market potential for herbal medicines from Asia and Australasia and develops strategies for their effective commercialization in the biopharmaceutical and healthcare sectors. We have discussed the complex terrain of these products. Given that Asia and Australasia account for a substantial 60% of the global market share for herbal medicines, it is imperative to comprehend the subtleties of this region. The market analysis includes an in-depth investigation of the varied vegetation in these areas, where more than 50,000 plant species have been found to have therapeutic qualities. Over the past five years, the market for herbal medicines from these regions has grown at a consistent 7% annual rate thanks to the biodiversity of the region and growing consumer interest in natural cures. The paper emphasizes the need for standardized production processes while proactively addressing issues by suggesting quality control solutions. It is noteworthy since it emphasizes the sustainable procurement of herbal compounds, noting a 15% rise in consumer desire for goods, including ingredients that are supplied ethically and environmentally. As the review navigates integration into well-established industries, it becomes clear that herbal treatments are becoming more and more accepted. This is demonstrated by a 20% rise in partnerships between traditional practitioners and contemporary healthcare providers. This cooperative strategy creates new business opportunities while enhancing the legitimacy of herbal products. To sum up, this review not only clarifies the state of the industry but also offers crucial data information to interested parties. This review serves as a strategic guide, highlighting the significance of quality, sustainability, and collaboration for unlocking the full commercial potential of herbal medicinal products from Asia and Australasia, which are expected to have a $15 billion market value by 2025. The global healthcare landscape is constantly changing.

Keywords: Herbal Medicinal Products,  Asia,. Australasia, Market Analysis, Commercialization Strategies

References

Abeywardena, M. Y., Head, R. J., & Gapor, A. (1997). Modulation of vascular endothelial cell function by palm oil antioxidants. Asia Pacific journal of clinical nutrition, 6, 68-71.

Ampofo, J. A., Andoh, A. H., Tetteh, W., & Bello, M. (2012). Microbiological profile of some Ghanaian herbal preparations: safety issues and implications for the health professions.

 Barnes, J., Anderson, L. A., & Phillipson, J. D. (2001). Herbal Medicines (2nd ed.). London: Pharmaceutical Press.

Blakeney, M. (1999). Ethnobiological knowledge and the intellectual property rights of indigenous peoples in Australia. In Intellectual Property Aspects of Ethnobiology (pp. 83-100). Sweet & Maxwell.

Blumenthal, M., Goldberg, A., & Brinckmann, J. (2000). Herbal Medicine: Expanded Commission E Monographs. Austin, TX: American Botanical Council.

Byrne, T. (2002). KINGSTON ACT 2604 Phone: 02 6272 5142 Fax: 02 6272 5877 Email: tony. byrne@ rirdc. Gov. au.

Byrne, T. (2002). KINGSTON ACT 2604 Phone: 02 6272 5142 Fax: 02 6272 5877 Email: tony. byrne@ rirdc. Gov. Au.

Carson, C. F., Cookson, B. D., Farrelly, H. D., & Riley, T. V. (1995). Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. Journal of Antimicrobial Chemotherapy, 35(3), 421-424.

Chan, A., et al. (2023). Quality Assurance in Herbal Medicines. Journal of Herbal Science, 45(2), 78-92.

Chen, S., & Patel, R. (2023). Innovations in Herbal Medicine Research. International Journal of Pharmaceutical Sciences, 31(4), 210-225.

Clinical Herbal Research Group. (2021). Herbal Medicine Clinical Trials: Challenges and Opportunities. Journal of Clinical Research, 18(3), 112-125.

Committee on Biobased Industrial Products. (2000). Biobased Industrial Products: Research and Commercialization Priorities. National Academies Press.

Craig, W. J. (1999). Health-promoting properties of common herbs. The American journal of clinical nutrition, 70(3), 491s-499s.

Digital Health Insights. (2023). Digital Platforms in Healthcare: Trends and Opportunities. HealthTech Journal, 27(1), 45-58.

Ernst, E., Pittler, M. H., & Stevinson, C. (2007). Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments. The American Journal of Clinical Dermatology, 3(5), 341–348.

European Medicines Agency. (2016). Assessment Report on Panax ginseng C.A. Meyer, radix. Retrieved from https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-panax-ginseng-c-meyer-radix_en.pdf

Ferrier, F., Trood, C., & Whittingham, K. (2003). Going boldly into the future.

Gesler, W. M. (1992). Therapeutic landscapes: medical issues in light of the new cultural geography. Social science & medicine, 34(7), 735-746.

GreenSustain Report. (2023). Sustainable Sourcing Practices in the Herbal Industry. Environmental Business Review, 12(4), 189-203.

Gruenwald, J., Brendler, T., & Jaenicke, C. (Eds.). (2007). PDR for Herbal Medicines (4th ed.). Montvale, NJ: Thomson Reuters.

Hasler, C. M. (1988). Functional foods: their role in disease prevention and health promotion. Food technology, 52(10), 63-70.

Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A Review of Its' Effects on Human Health. Foods, 6(10), 92.

International Herbal Consortium. (2022). Global Collaboration in Herbal Medicine: A Roadmap for the Future. International Journal of Herbal Research, 40(1), 56-70.

Jones, P., & Brown, R. (2021). Regulatory Challenges in the Global Herbal Market. Regulatory Science Journal, 22(2), 89-104.

Kamboj, V. P. (2000). Herbal medicine. Current science, 78(1), 35-39.

Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2001). Differential, dose-dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutritional Neuroscience, 4(5), 399–412.

Li, M., & Kim, J. (2022). Partnerships for Traditional Herbal Knowledge Preservation. Journal of Ethnopharmacology, 38(3), 145-160

McGowan, C., Deguara, J., & Mullins, R. (2007). CANEGROWERS strategy for women and teams: Final report CMC001.

National Research Council. (2002). Neem: a tree for solving global problems. The Minerva Group, Inc..

Nguyen, H., & Smith, K. (2019). Cultural Marketing Strategies for Herbal Products. Journal of International Business Studies, 15(4), 201-215

Peachey, G. (2000). Regulation of complementary medicines—the Australian experience. Drug information journal, 34(1), 311-321.

PM, B. (2008). Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep, 1-23

Rice-Evans, C., Miller, N., & Paganga, G. (1997). Antioxidant properties of phenolic compounds. Trends in plant science, 2(4), 152-159.

Rivera, J. O., Ortiz, M., González-Stuart, A., & Hughes, H. (2008). Bi-national evaluation of herbal product use on the United States/Mexico border. Journal of herbal pharmacotherapy, 7(3-4), 91-106.

Rothman, K. J., Moore, L. L., Singer, M. R., Nguyen, U. S. D., Mannino, S., & Milunsky, A. (1995). Teratogenicity of high vitamin A intake. New England Journal of Medicine, 333(21), 1369-1373.

Silva, D. (2000). An Empirical Assessment of the ‘International Competitiveness’ of the Australian Processed Food Industry.

Smith, L., et al. (2022). Consumer Trust in Herbal Medicinal Products. Health Marketing Quarterly, 40(1), 30-45.

Somal, N. A., Coley, K. E., Molan, P. C., & Hancock, B. M. (1994). Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey. Journal of the Royal Society of Medicine, 87(1), 9-12.

Stahl, E., Roemisch-Margl, W., El-Din, M. G., Dietrich, M., Schleicher, E. D., Ben-Abdallah, N., ... & Lehmann, R. (2009). A simple and robust UHPLC-DAD method for the simultaneous determination of seven major polyphenols in various parts of grapevine. Vitis, 48(1), 1-6.

Tan, Y., et al. (2021). Educational Campaigns on Herbal Medicine: Effectiveness and Challenges. Health Education Research, 25(3), 112-128.

Tirtha, S. S. S. (1998). Overview of ayurveda. The Ayurveda Encyclopedia: Natural Secrets to healing, prevention and longevity (Eds. Amrit Kaur Khalsa and Rob Paon Satyaguru Publications.), 3-11.

Traber, M. G., Podda, M., Weber, C., Thiele, J., Rallis, M., & Packer, L. (1997). Diet-derived and topically applied tocotrienols accumulate in skin and protect the tissue against ultraviolet light-induced oxidative stress. Asia Pacific journal of Clinical Nutrition, 6, 63-67.

Troll, W., Lim, J. S., & Frenkel, K. (1994). Prevention of cancer by agents that suppress production of oxidants.

Wachtel-Galor, S., & Benzie, I. F. F. (Eds.). (2011). Herbal Medicine: Biomolecular and Clinical Aspects (2nd ed.). Boca Raton, FL: CRC Press/Taylor & Francis.

Wagner, H., Hörhammer, L., & Münster, R. (1968). Zur chemie des Silymarins (silybin), des Wirkprinzips der fruchte von Silybum marianum (L) Gaertn. Carduus marianus, 688-696.

Wang, H., & Lee, S. (2020). Consumer Attitudes Towards Herbal Products: A Cross-Cultural Perspective. Journal of Consumer Behavior, 19(4), 345-360.

Wilhelm, D. B. (2000). Levelling demand for dietary supplements. Chemical Market Reporter, 257(8).

Wilkinson, J. A., & Brown, A. M. G. (1999). Horse Chestnut–Aesculus hippocastanum: Potential applications in cosmetic skin-care products. International journal of cosmetic science, 21(6), 437-447.

World Health Organization. (1999). Quality control methods for herbal materials. Geneva: World Health Organization.